ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KMK Kromek Group Plc

6.05
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.05 5.80 6.30 6.05 6.05 6.05 109,127 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -5.93 36.31M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.05p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.25p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £36.31 million. Kromek has a price to earnings ratio (PE ratio) of -5.93.

Kromek Share Discussion Threads

Showing 4801 to 4822 of 7300 messages
Chat Pages: Latest  196  195  194  193  192  191  190  189  188  187  186  185  Older
DateSubjectAuthorDiscuss
14/7/2021
13:19
Ok AQC888, in this world nothing is guaranteed we all know that.
Kromek are the only Tech company in the UK and arguably the US that have had such backing to develop thier Bio dection units, they were originally for multi patho virus / bacterial / anthrax detection, they've in parallel in record time developed a pure Covid unit being tested/trialed and now we're told today as I understand -
Technically assessed for accuracy and performance by the NHS...so if you like a 3rd party accreditation. There is no 'airborne viral' standards actually to meet so they are in communication with gov bodies to gain accredition etc..we know its as accurate as PCR.

With no doubt news to follow.

The other core parts of the business are back on track and firing on all cylinders, that was the facts we heard from Kromek this morning.

There's none if the skulldungery you imply...it's a woefully unrealistic expectation of what can be humanly achieved by any tech company designing and testing a new product that seems to frustrate you. You're probably not alone as not everyone has a technical mind or product development knowledge.

Things are all starting to line up here.

Just coming thro what for most companies has been the worse period imaginable with Covids shutdowns Kromek's results today are more than impressive to many.

33mick
14/7/2021
12:51
What else exactly was inaccurate/misleading?
aqc888
14/7/2021
12:50
33mick, winning government funding for a product does not equate to, or guarantee, a successful product being developed.
aqc888
14/7/2021
12:34
QP - where are you viewing the presentation?

I think the more who see it the better.

It takes away from the trials and focusses on the whole company, with the bio-detection as an exciting bonus.

dougmachin
14/7/2021
12:32
AQC888...it's very frustrating reading your inaccurate and misleading posts.
You have a very poor grasp of information you read and hear and for some reason decide to believe another version of imagined events.

Technology and Science and Product development...world first fully US/UK gov funded..seems completely missed by you!!

Nothing you say I find correct or factual...sorry your the Muppet here.

33mick
14/7/2021
12:29
Amazing results buying more on this fall which is unwarranted
ch1ck
14/7/2021
12:17
Very predictable results. A lot of exciting news in the pipeline, as always... Past promises forgotten - no results from the trial. (Results to the trial were to come in the coming days, last month). Recovery of the £13m AROC exception (from 2020) is now considered doubtful and it has been revealed it relates to doubtful/bad debts (rather than written off stock held by Kromek - as Simon Thompson stated).

Given Simon Thompson seems to have been mislead not even a repeat tip can be expected. I’m doubtful that the Chinese government don’t consider workers for a hospital imaging system as essential workers and refuse them entry.

Very frustrated by the lack of details regarding the trial. Supposedly they have been in trials for over 6months. (Although as we learned from the Teeside Mayor this was not the case, they only started 1month ago).

I can understand the trials are ongoing and they are refining the system for different environments. But no details at all regarding the trials other than vague references to them being as good as pcr tests??? If that’s the case why aren’t they releasing specific details on this information to show how wonderful it is?? We’re just left to ‘believe’; what the CEO tells us. Kromek is beginning to feel like being a member of a cult. Nobody is allowed to see any evidence of the game changer covid machine. We just have to listen and ‘believe’; in it. Alot of smoke and mirrors. Just enough information given about the biological pathogen detector to keep people holding on, but not any actual evidence of its effectiveness from the trials. Very frustrating.

aqc888
14/7/2021
12:11
QP - Yep, Paul Farquhar CFO was present and gave a good run through of figures at the start. He also answered questions that were best answered by him. I took a bunch of "notes" which I hope to have a good look at soon.
dougmachin
14/7/2021
11:53
Doug,

Thanks.

Lots of red-herrings with Kromek. The $159m 4/4/14 contract..... The ventilator contract....

They obviously knew some time back that the ventilator project was cratering. I just wonder to myself if it would have been good corporate etiquette to mention how it was progressing.


Question please. Haven't had the chance to view the presentation but will do in due course.

Was the Finance Director present and did (as customary in annual results presentations) the Finance Director give a thorough run-through of figures?

thanks.

ALL IMO. DYOR.
QP

quepassa
14/7/2021
11:47
QuePassa - I think you're chasing a red herring here. Ventilators were a potential that never came about. That's all. If you wanna beat KMK with a stick, I would say there's other ways to do it. Ventilators aren't a part of KMK's core business. Agreed, they probably never should have mentioned anything in an RNS unless it was actually 100% going to result in sales, as this leads to 'boy who cried wolf' affect.

From the presentation, I've moved so far on from that RNS. It's history. Not KMK's finest moment. But a small blip that in no way has affected KMK's core business.

The presentation showed a quality company with some really exciting possibilities. Let's see where the share price is, this time next year. I am watching and would now add more.

dougmachin
14/7/2021
11:43
I bet the Navy s Covid problems were related to this latest MOD contract.

Today's Proactive Investors comments.

"Kromek targets record annual revenues after securing new contracts"

"In Kromek’s new target area of biological-threat detection, the detection specialist has been awarded a £349,000 contract with the UK Ministry of Defence to develop its technology to meet defence and security"

33mick
14/7/2021
11:22
Thank you Doug for asking the question and eliciting an answer on the Ventilators.

Appreciated.

So despite the fanfare of their announcement, now we know according to your response that ZERO VENTILATORS were made during a time of grave national crisis.

And a curious response that it was an issue with the UK government , not theirs.

Must say , I don't really comprehend that. At that time, I thought the UK government was desperate for ventilators.


But putting that conundrum to one side, in the same 15/4/20 RNS announcing the VENTILATOR project, Kromek said that the ventilators were to be sold in the UK and GLOBALLY.

" Following the signing of a license agreement, which is expected shortly, Kromek intends to sell the ventilators in the UK and globally."


Well, what about their GLOBAL sales of ventilators? Surely that can't be laid at the door of the UK government. What happened there?




ALL IMO. DYOR.
QP

quepassa
14/7/2021
11:21
Today..BBC news-

I was amazed there was no talk of it as she sailed out of Portsmouth only to return a few weeks later..and leave at a latter date.

All those matlos were double jabbed, double PCR tested before boarding and it appears nothing can detect it well enough.

'An outbreak of Covid-19 has been confirmed on the Royal Navy's flagship, HMS Queen Elizabeth.

The BBC has been told there have been around 100 cases on the aircraft carrier, which is part way through a world tour.

Several other warships in the fleet accompanying it are also affected.

Defence Secretary Ben Wallace said all crew on the deployment had received two doses of a Covid-19 vaccine and the outbreak was being managed.

HMS Queen Elizabeth is about a quarter of the way through a 28-week deployment leading the Carrier Strike Group (CSG).

It has now entered the Indian Ocean, and the Royal Navy says it is due to continue on its voyage to Japan later this year.'

33mick
14/7/2021
11:05
Very good write up Doug, I'm glad I tuned in, seems all very positive to me in all areas, the future potential bio detection/monitoring units sales are as you state not factored in to any projections. So to my eyes a very exciting story to follow.

NHS based 3rd party accuracy and sensitivity tests being carried out If I heard correctly?

Manufacturing/Production lines being sounded out.

And even the Chinese/Asian customer still could come good. All products in store awaiting onsite installation when techies can travel I believe.

33mick
14/7/2021
10:50
[1] I asked about any fundraising, answer was 'no' in the short / medium term.
Maybe for a specific acquisition at some point, but a firm 'no'.

[2] The 13 million Chinese product system is still there and will be delivered as a system as soon as people movement opens up.

[3] The ventilators could have been made, but 0 were made. UK government, not KMK issue. Main point here though is that was just making something under license. The bio-detection excitement is totally different, this is creating intellectual property rights that is funded by 3 different agencies. So any skepticism felt due to the ventilators, shouldn't be carried over to the bio-detection.

[4] On track to deliver significant revenue growth for full year 2022. 15 million revenue for '22, which is 50% growth (am I correct here?). This already has 76% visibility and the remainder should be easily achieved through pipeline. This does not include any of the bio-detection either (I think).

[5] The medical imaging side sounded exciting too. 100 million possibility opening up. KMK and 1 competitor only, where KMK has the edge. Could be exciting.

I feel after watching that more confident in this company than I ever have been. Their core businesses are also on the move. It's not just about COVID and pathogen detection. There are multiple milestones that can be achieved in 2022 to allow commercial development of the bio-threat detection systems.

A lot more too. Watched and wrote this whilst teaching the wife to drive!

Hope helps, cheers.

DM

dougmachin
14/7/2021
10:12
At what point do you consider a strategic review of your ip / assets to determine if their true value would be achieved if part of a larger well financed company.
slicethepie
14/7/2021
09:53
Yes.

Please ask a simple question.

How many VENTILATORS sold .


Thank you.

quepassa
14/7/2021
09:44
Am on the presentation, any questions post them here.
I can add them to the presentation chat.
Cheers

dougmachin
14/7/2021
09:23
anyone has the link to webinar presentation at 9.30
ali47fish
14/7/2021
09:14
Thanks Doug, had probs replying to you.
Fat finger this end .hahaa
Or the Ipa I was trialing.

33mick
14/7/2021
09:12
Kromek GroupResearch note and CEO videoSymbol  KMK   Listing AIM    Share Price 16p    Mkt Cap £69m  Sector Tech '3-2-1...we have lift-off' for all of KMK's end markets The 19th July 2021 will hopefully 'go down' in UK history as the day Covid switched from being a pandemic to an endemic disease. Pent-up demand & acceleration of deferred OEM product launches should also provide a multi-year tailwind for Kromek's end markets of Medical Imaging, Security Screening, and Homeland Security. Furthermore, their airborne Covid detector is already making great strides, having commenced field trials in schools, airports (eg Teesside International) and other locations under a £1.25m project with funding from Innovate UK. Plus the device's efficacy is presently being clinically validated by 3rd party laboratories. Where it is demonstrating "very positive" performance in terms of sensitivity and specificity. In fact, comparable with 'gold standard' PCR tests. Today's FY21 results saw adjusted FY'21 EBITDA (pre share based payments) come in slightly better than our estimates at -£1.7m (vs ED -£1.9m) on turnover of £10.35m (ED £10.0m). Alongside net cash closing April at £7.4m (split cash +£15.6m, debt £8.2m), after Feb's £13.0m (gross) fundraise at 15p. We reiterate our 26p/share valuation based on the strong rebound in demand. Noting the stock at 16p trades on 4.1x FY22 EV/sales vs 5.0x for the sector, yet is set to grow materially faster over the next few years.
dougmachin
14/7/2021
08:51
The share price still at the Foot of our stairs. Hope something good in the 09:30 presentation.
b00mb0y
Chat Pages: Latest  196  195  194  193  192  191  190  189  188  187  186  185  Older

Your Recent History

Delayed Upgrade Clock